Neonatal
Conjunctivitis Therapeutics Market Size, Growth, Trends, Analysis and Forecast
- 2031

The
global neonatal conjunctivitis therapeutics market is anticipated to grow at a
significant CAGR during the forecast period (2024-2031). Conjunctivitis is a
kind of eye condition, which is commonly known as pink eye since the
inflammation due to the infection makes the white part of the eye look
red/pink. Neonatal conjunctivitis is also known as ophthalmia neonatorum.
Neonatal conjunctivitis occurs in infants within the first 28 days of birth. In
the first place, the disease gets acquired during the passage of the neonate
through the infected birth canal. Some of the common microorganisms that cause
the infection include Chlamydia trachomatis, Staphylococcus aureus,
Staphylococcus epidermis, Escherichia coli, Neisseria gonorrhoea, other
gram-negative bacteria and Herpes Simplex Virus.

Get Free Sample link @ https://www.omrglobal.com/request-sample/neonatal-conjunctivitis-therapeutics-market

Another
factor contributing to the market growth includes the increasing awareness
among the global population that surge the demand for treatment of neonatal
conjunctivitis. As a result, several biopharmaceutical companies have planned
to invest in R&D initiatives to novel drugs and therapies for the treatment
of this disorder. For instance, in July 2020, Zhaoke Ophthalmology
Pharmaceutical Ltd. and IACTA Pharmaceuticals signed an agreement to accelerate
the development of drugs called IC 265 and IC 270. The former is developed to
treat dry eye and the latter for ocular allergy.

Some
key players operating in the market include Merck & Co. Inc., Akorn Inc,
Pfizer Inc., Bayer AG, among others. These players are aiming at strengthening
their position in the market by adopting various strategies as mergers and
acquisitions, partnerships, collaborations, new product launch and development
in the existing product portfolio, and so on.

Full report of Neonatal Conjunctivitis Therapeutics Market available
@ https://www.omrglobal.com/industry-reports/neonatal-conjunctivitis-therapeutics-market

Market
Coverage

• Segment Covered


• Regions Covered- Globally

Competitive
Landscape: Merck & Co. Inc., Akorn Inc, Pfizer Inc., Bayer AG, among
others.               

Key
questions addressed by the report

• What is the market growth
  rate?


• Which segment and region
  dominates the market in base year?


• Which segment and region
  will project fastest growth in the market?


• How COVID-19 impacted the
  market?

o             Recovery Timeline

o             Deviation from pre-COVID forecast

o             Most affected region and segment

• Who is the leader in the
  market?


• How players are addressing
  challenges to sustain growth?


• Where is the investment
  opportunity?

Global
Neonatal Conjunctivitis Therapeutics Market by Segment

By
Treatment Administration 

•                
Oral

•                
Topical

•                
Intramuscular and Intravenous

By
Distribution Channel 

•                
Hospital Pharmaciess

•                
Retail Pharmacies

•                
Drug Stores

•                
E-Commerce

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/neonatal-conjunctivitis-therapeutics-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.